ACHC

SEC source: 0000899243-18-030667 · doc4.xml · derivative · entry 2

GRIECO WILLIAM · CIK 0001248557 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2018-12-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000899243-18-030667 · doc4.xml · nonDerivative · entry 1

GRIECO WILLIAM · CIK 0001248557 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,406

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000899243-19-003451 · doc5.xml · nonDerivative · entry 2

Howard Christopher L · CIK 0001337573 · EVP, GC and Secretary

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 111,578

F1 · kind: This transaction involved a gift of 8,422 shares by the Christopher L. Howard Family 2017 Grantor Retained Annuity Trust to the reporting person.

F2 · kind: Mr. Howard expressly disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein.

F3 · ownership.nature: Includes 51,578 shares held by the Christopher L. Howard Family 2017 Grantor Retained Annuity Trust, 51,578 shares held by the Angie Parrott Howard Family 2017 Grantor Retained Annuity Trust and 8,422 shares held by the reporting person's spouse.

SEC source: 0000899243-19-003451 · doc5.xml · nonDerivative · entry 1

Howard Christopher L · CIK 0001337573 · EVP, GC and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,761

F1 · kind: This transaction involved a gift of 8,422 shares by the Christopher L. Howard Family 2017 Grantor Retained Annuity Trust to the reporting person.

SEC source: 0000899243-18-028069 · doc4.xml · nonDerivative · entry 1

WAUD REEVE B · CIK 0001421620 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 793,628

F1 · shares: Represents shares sold pursuant to a Rule 10b-5 plan adopted by the Halcyon Exempt Family Trust (the "Halcyon Trust") on March 15, 2018.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $45.00 to $45.05, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F3 · balance_after: The shares are owned of record as follows: (i) 355,912 shares by the Halcyon Exempt Family Trust (the "Halcyon Trust"), (ii) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (iii) 37,493 shares by Waud Capital Partners, L.L.C. ("WCP LLC"), (iv) 183,445 shares by the Reeve B. Waud Jr. 2012 Family Trust (the "2012 RBW Jr Family Trust"), and (v) 183,445 shares by the Cecily R.M. Waud 2012 Family Trust (the "2012 CRMW Family Trust").

F4 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock described in Footnote (3) above by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being married to Ms. Waud, (C) his being the sole manager of WCP LLC, and (D) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries.

F5 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.

SEC source: 0000899243-18-020783 · doc4.xml · nonDerivative · entry 1

WAUD REEVE B · CIK 0001421620 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 835,493

F1 · shares: Represents shares sold pursuant to a Rule 10b-5 plan adopted by the Halcyon Exempt Family Trust (the "Halcyon Trust") on March 15, 2018.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $45.00 to $45.02, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F3 · balance_after: The shares are owned of record as follows: (i) 397,777 shares by the Halcyon Exempt Family Trust (the "Halcyon Trust"), (ii) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (iii) 37,493 shares by Waud Capital Partners, L.L.C. ("WCP LLC"), (iv) 183,445 shares by the Reeve B. Waud Jr. 2012 Family Trust (the "2012 RBW Jr Family Trust"), and (v) 183,445 shares by the Cecily R.M. Waud 2012 Family Trust (the "2012 CRMW Family Trust").

F4 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock described in Footnote (3) above by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being married to Ms. Waud, (C) his being the sole manager of WCP LLC, and (D) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries.

F5 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.

SEC source: 0000899243-18-011557 · doc4.xml · nonDerivative · entry 1

WAUD REEVE B · CIK 0001421620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,213

F1 · shares: The shares will vest in three equal annual installments beginning May 3, 2019.

SEC source: 0000899243-18-011538 · doc4.xml · nonDerivative · entry 1

Bissell E. Perot · CIK 0001420194 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,575

F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 3, 2019.

SEC source: 0000899243-18-011536 · doc4.xml · nonDerivative · entry 1

Petrie William M · CIK 0001302671 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,364

F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 3, 2019.

SEC source: 0000899243-18-011537 · doc4.xml · nonDerivative · entry 1

GRIECO WILLIAM · CIK 0001248557 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,406

F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 3, 2019.

SEC source: 0000899243-18-011497 · doc4.xml · nonDerivative · entry 1

Miquelon Wade D · CIK 0001365176 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,643

F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 3, 2019.

SEC source: 0000899243-18-011540 · doc4.xml · nonDerivative · entry 1

Gregg Vicky B · CIK 0001510304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,717

F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 3, 2019.

SEC source: 0000899243-18-011637 · doc4.xml · nonDerivative · entry 1

Gordon Christopher R · CIK 0001432313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,328

F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 3, 2019.

SEC source: 0000899243-18-007595 · doc4.xml · nonDerivative · entry 1

WAUD REEVE B · CIK 0001421620 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 843,628

F1 · shares: Represents shares sold pursuant to a Rule 10b-5 plan adopted by the Halcyon Exempt Family Trust (the "Halcyon Trust") on December 14, 2017.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $42.00 to $42.13, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F3 · balance_after: The shares are owned of record as follows: (i) 405,912 shares by the Halcyon Trust, (ii) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (iii) 37,493 shares by Waud Capital Partners, L.L.C. ("WCP LLC"), (iv) 183,445 shares by the Reeve B. Waud Jr. 2012 Family Trust (the "2012 RBW Jr Family Trust"), and (v) 183,445 shares by the Cecily R.M. Waud 2012 Family Trust (the "2012 CRMW Family Trust").

F4 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being married to Ms. Waud, (C) his being the sole manager of WCP LLC, and (D) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries.

F5 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.

SEC source: 0000899243-18-007733 · doc4.xml · nonDerivative · entry 2

GOLDBERG RANDALL P · CIK 0001533818 · VP of Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,357

SEC source: 0000899243-18-007733 · doc4.xml · nonDerivative · entry 1

GOLDBERG RANDALL P · CIK 0001533818 · VP of Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,757

SEC source: 0000899243-18-007418 · doc4.xml · nonDerivative · entry 2

WAUD REEVE B · CIK 0001421620 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 851,326

F1 · shares: Represents shares sold pursuant to a Rule 10b-5 plan adopted by the Halcyon Exempt Family Trust (the "Halcyon Trust") on December 14, 2017.

F3 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $42.00 to $42.27, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F4 · balance_after: The shares are owned of record as follows: (i) 413,610 shares by the Halcyon Trust, (ii) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (iii) 37,493 shares by Waud Capital Partners, L.L.C. ("WCP LLC"), (iv) 183,445 shares by the Reeve B. Waud Jr. 2012 Family Trust (the "2012 RBW Jr Family Trust"), and (v) 183,445 shares by the Cecily R.M. Waud 2012 Family Trust (the "2012 CRMW Family Trust").

F5 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being married to Ms. Waud, (C) his being the sole manager of WCP LLC, and (D) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries.

F6 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.

SEC source: 0000899243-18-007418 · doc4.xml · nonDerivative · entry 1

WAUD REEVE B · CIK 0001421620 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 856,726

F1 · shares: Represents shares sold pursuant to a Rule 10b-5 plan adopted by the Halcyon Exempt Family Trust (the "Halcyon Trust") on December 14, 2017.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $42.00 to $42.07, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F5 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being married to Ms. Waud, (C) his being the sole manager of WCP LLC, and (D) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries.

F6 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.

SEC source: 0000899243-18-006556 · doc4.xml · nonDerivative · entry 5

WAUD REEVE B · CIK 0001421620 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 893,628

F1 · shares: Represents shares sold pursuant to a Rule 10b-5 plan adopted by the Halcyon Exempt Family Trust (the "Halcyon Trust") on December 14, 2017.

F6 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $40.00 to $40.29, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F7 · balance_after: The shares are owned of record as follows: (i) 455,912 shares by the Halcyon Trust, (ii) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (iii) 37,493 shares by Waud Capital Partners, L.L.C. ("WCP LLC"), (iv) 183,445 shares by the Reeve B. Waud Jr. 2012 Family Trust (the "2012 RBW Jr Family Trust"), and (v) 183,445 shares by the Cecily R.M. Waud 2012 Family Trust (the "2012 CRMW Family Trust").

F8 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being married to Ms. Waud, (C) his being the sole manager of WCP LLC, and (D) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries.

F9 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.

SEC source: 0000899243-18-006556 · doc4.xml · nonDerivative · entry 4

WAUD REEVE B · CIK 0001421620 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 943,628

F1 · shares: Represents shares sold pursuant to a Rule 10b-5 plan adopted by the Halcyon Exempt Family Trust (the "Halcyon Trust") on December 14, 2017.

F5 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $39.91 to $39.96, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F8 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being married to Ms. Waud, (C) his being the sole manager of WCP LLC, and (D) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries.

F9 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.

SEC source: 0000899243-18-006556 · doc4.xml · nonDerivative · entry 3

WAUD REEVE B · CIK 0001421620 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 944,708

F1 · shares: Represents shares sold pursuant to a Rule 10b-5 plan adopted by the Halcyon Exempt Family Trust (the "Halcyon Trust") on December 14, 2017.

F4 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $38.91 to $39.90, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F8 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being married to Ms. Waud, (C) his being the sole manager of WCP LLC, and (D) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries.

F9 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.

SEC source: 0000899243-18-006556 · doc4.xml · nonDerivative · entry 2

WAUD REEVE B · CIK 0001421620 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 1,005,737

F1 · shares: Represents shares sold pursuant to a Rule 10b-5 plan adopted by the Halcyon Exempt Family Trust (the "Halcyon Trust") on December 14, 2017.

F3 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $37.90 to $38.84, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F8 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being married to Ms. Waud, (C) his being the sole manager of WCP LLC, and (D) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries.

F9 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.

SEC source: 0000899243-18-006556 · doc4.xml · nonDerivative · entry 1

WAUD REEVE B · CIK 0001421620 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 1,075,878

F1 · shares: Represents shares sold pursuant to a Rule 10b-5 plan adopted by the Halcyon Exempt Family Trust (the "Halcyon Trust") on December 14, 2017.

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $36.90 to $37.88, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F8 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being married to Ms. Waud, (C) his being the sole manager of WCP LLC, and (D) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries.

F9 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.

SEC source: 0000899243-18-006750 · doc4.xml · nonDerivative · entry 1

Fincher Ronald Morgan · CIK 0001448040 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,415

F1 · shares: Shares will vest over a 4-year period in equal yearly installments beginning March 2, 2019.

SEC source: 0000899243-18-006751 · doc4.xml · nonDerivative · entry 1

JACOBS JOEY A · CIK 0001243878 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 284,199

F1 · shares: Shares will vest over a 4-year period in equal yearly installments beginning March 2, 2019.

SEC source: 0000899243-18-006744 · doc4.xml · nonDerivative · entry 1

TURNER BRENT · CIK 0001243882 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,440

F1 · shares: Shares will vest over a 4-year period in equal yearly installments beginning March 2, 2019.

SEC source: 0000899243-18-006749 · doc4.xml · nonDerivative · entry 1

Howard Christopher L · CIK 0001337573 · EVP, GC and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,339

F1 · shares: Shares will vest over a 4-year period in equal yearly installments beginning March 2, 2019.

SEC source: 0000899243-18-006745 · doc4.xml · nonDerivative · entry 1

Duckworth David M. · CIK 0001555047 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,974

F1 · shares: Shares will vest over a 4-year period in equal yearly installments beginning March 2, 2019.

SEC source: 0000899243-18-006148 · doc4.xml · nonDerivative · entry 3

GOLDBERG RANDALL P · CIK 0001533818 · VP of Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,982

SEC source: 0000899243-18-006148 · doc4.xml · nonDerivative · entry 2

GOLDBERG RANDALL P · CIK 0001533818 · VP of Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,542

SEC source: 0000899243-18-006151 · doc4.xml · nonDerivative · entry 2

Fincher Ronald Morgan · CIK 0001448040 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,168

F2 · shares: Shares received upon vesting of performance vesting restricted stock units awarded on March 29, 2017.

SEC source: 0000899243-18-006151 · doc4.xml · nonDerivative · entry 1

Fincher Ronald Morgan · CIK 0001448040 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,422

F1 · shares: Shares received upon vesting of performance vesting restricted stock units awarded on February 24, 2015.

SEC source: 0000899243-18-006150 · doc4.xml · nonDerivative · entry 2

JACOBS JOEY A · CIK 0001243878 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 241,452

F2 · shares: Shares received upon vesting of performance vesting restricted stock units awarded on March 29, 2017.

SEC source: 0000899243-18-006150 · doc4.xml · nonDerivative · entry 1

JACOBS JOEY A · CIK 0001243878 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 215,117

F1 · shares: Shares received upon vesting of performance vesting restricted stock units awarded on February 24, 2015.

SEC source: 0000899243-18-006153 · doc4.xml · nonDerivative · entry 2

TURNER BRENT · CIK 0001243882 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,981

F2 · shares: Shares received upon vesting of performance vesting restricted stock units awarded on March 29, 2017.

SEC source: 0000899243-18-006153 · doc4.xml · nonDerivative · entry 1

TURNER BRENT · CIK 0001243882 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,677

F1 · shares: Shares received upon vesting of performance vesting restricted stock units awarded on February 24, 2015.

SEC source: 0000899243-18-006154 · doc4.xml · nonDerivative · entry 2

Howard Christopher L · CIK 0001337573 · EVP, GC and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,191

F2 · shares: Shares received upon vesting of performance vesting restricted stock units awarded on March 29, 2017.

SEC source: 0000899243-18-006154 · doc4.xml · nonDerivative · entry 1

Howard Christopher L · CIK 0001337573 · EVP, GC and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,623

F1 · shares: Shares received upon vesting of performance vesting restricted stock units awarded on February 24, 2015.

SEC source: 0000899243-18-006149 · doc4.xml · nonDerivative · entry 2

Duckworth David M. · CIK 0001555047 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,913

F2 · shares: Shares received upon vesting of performance vesting restricted stock units awarded on March 29, 2017.

SEC source: 0000899243-18-006149 · doc4.xml · nonDerivative · entry 1

Duckworth David M. · CIK 0001555047 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,954

F1 · shares: Shares received upon vesting of performance vesting restricted stock units awarded on February 24, 2015.

SEC source: 0000899243-18-006148 · doc4.xml · derivative · entry 4

GOLDBERG RANDALL P · CIK 0001533818 · VP of Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,000

Underlying: Common Stock · 3,000 shares

Expires 2028-02-28

F2 · derivative.exercise_date: The options will vest over a 4-year period in equal yearly installments beginning February 28, 2019.

SEC source: 0000899243-18-006148 · doc4.xml · nonDerivative · entry 1

GOLDBERG RANDALL P · CIK 0001533818 · VP of Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,942

F1 · shares: Shares will vest over a 4-year period in equal yearly installments beginning February 28, 2019.

SEC source: 0000899243-18-005643 · doc4.xml · nonDerivative · entry 2

GOLDBERG RANDALL P · CIK 0001533818 · VP of Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,142

SEC source: 0000899243-18-005643 · doc4.xml · nonDerivative · entry 1

GOLDBERG RANDALL P · CIK 0001533818 · VP of Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,358

SEC source: 0000899243-18-003120 · doc4.xml · nonDerivative · entry 1

Fincher Ronald Morgan · CIK 0001448040 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,618

SEC source: 0000899243-18-003125 · doc4.xml · nonDerivative · entry 1

Duckworth David M. · CIK 0001555047 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,352

SEC source: 0000899243-18-003124 · doc4.xml · nonDerivative · entry 1

GOLDBERG RANDALL P · CIK 0001533818 · VP of Business Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,592

SEC source: 0000899243-17-029059 · doc4.xml · nonDerivative · entry 2

WAUD REEVE B · CIK 0001421620 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 1,093,628

F5 · shares: Represents a pro rata distribution of shares by Crystal Cove LP to its limited partners for no consideration : (i) 3,978 shares to Mr. Waud, (ii) 424,799 to the Reeve B. Waud 2011 Family Trust (the "2011 Family Trust"), (iii) 183,445 shares to the Reeve B. Waud Jr. 2012 Family Trust (the "2012 RBW Jr Family Trust"), and (iv) 183,445 shares to the Cecily R.M. Waud 2012 Family Trust (the "2012 CRMW Family Trust"). The limited partners acquired their indirect interest in the shares held by Crystal Cove LP as a result of gifts from Mr. Waud and certain affiliated family trusts. Mr. Waud may be deemed to retain an indirect beneficial ownership in all of the shares distributed by Crystal Cove LP (other than shares distributed to him personally) by virtue of the relationships described in Footnote (7).

F6 · balance_after: The shares are owned of record as follows: (i) 231,113 shares by the Halcyon Trust, (ii) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (iii) 37,493 shares by WCP LLC, (iv) 424,799 shares by the 2011 Family Trust, (v) 183,445 shares by the 2012 RBW Jr Family Trust, and (vi) 183,445 shares by the 2012 CRMW Family Trust.

F7 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his being the investment advisor of the Halcyon Trust and of the 2011 Family Trust of which Mr. Waud's children are beneficiaries, (B) his being married to Ms. Waud, (C) his being the sole manager of WCP LLC, and (D) his being the investment advisor of the 2012 RBW Jr Family Trust and the 2012 CRMW Family Trust of which Mr. Waud's grandchildren are beneficiaries.

F8 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.

SEC source: 0000899243-17-029059 · doc4.xml · nonDerivative · entry 1

WAUD REEVE B · CIK 0001421620 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 1,097,606

F1 · shares: Represents shares sold under Rule 144 by the Halcyon Exempt Family Trust (the "Halcyon Trust").

F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $31.57 to $32.16, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F3 · balance_after: The reported shares were owned of record as follows: (i) 231,113 shares by the Halcyon Trust, (ii) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (iii) 37,493 shares by Waud Capital Partners, L.L.C. ("WCP LLC"), and (iv) 795,667 by Crystal Cove LP.

F4 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (B) his being married to Ms. Waud, (C) his being the sole manager of WCP LLC and (D) his being the general partner of Crystal Cove LP.

F8 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.

SEC source: 0000899243-17-028875 · doc4.xml · derivative · entry 3

GRIECO WILLIAM · CIK 0001248557 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2017-12-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.